Jiangsu Hengrui Medicine financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Rev. Revenue
¥1.15B ¥1.18B ¥1.44B ¥1.98B ¥2.39B ¥3.03B ¥3.74B ¥4.55B ¥5.44B ¥6.20B ¥7.45B ¥9.32B ¥11.09B ¥13.84B ¥17.42B ¥23.29B ¥27.73B ¥25.91B ¥21.28B ¥22.82B ¥0.00M
GM % Gross Margin %
75.00% 80.50% 80.55% 83.28% 83.25% 82.71% 82.95% 82.73% 83.94% 81.32% 82.35% 85.27% 87.09% 86.62% 86.58% 87.47% 87.90% 85.50% 83.53% 84.39% 0.00%
OM Operating Margin
16.34% 19.15% 18.87% 18.49% 25.65% 22.73% 22.26% 22.35% 23.62% 22.99% 22.70% 25.90% 25.63% 25.84% 23.31% 23.62% 22.61% 14.58% 14.17% 18.30% 0.00%
EPS Earnings Per Share
¥0.02 ¥0.03 ¥0.07 ¥0.09 ¥0.09 ¥0.11 ¥0.13 ¥0.17 ¥0.19 ¥0.24 ¥0.34 ¥0.41 ¥0.49 ¥0.60 ¥0.78 ¥0.93 ¥0.66 ¥0.54 ¥0.65 ¥0.00
Div. Dividends
¥0.00 ¥0.00 ¥0.01 ¥0.01 ¥0.01 ¥0.01 ¥0.01 ¥0.02 ¥0.02 ¥0.02 ¥0.02 ¥0.03 ¥0.05 ¥0.06 ¥0.13 ¥0.16 ¥0.17 ¥0.16 ¥0.16 ¥0.20 ¥0.00
PR % Payout Ratio %
0 0 33.33% 14.29% 11.11% 11.11% 9.09% 15.38% 11.76% 10.53% 8.33% 8.82% 12.20% 12.24% 21.67% 20.51% 18.28% 24.24% 29.63% 30.77% 0
Sha. Shares
6253.97m 6253.97m 6253.97m 6253.97m 6253.97m 6253.97m 6253.97m 6292.09m 6292.09m 6292.09m 6324.68m 6328.91m 6,306m 6317.5m 6362.63m 6341.64m 6370.85m 5309.04m 6354.04m 0m 6358.56m
OCF Operating Cash Flow
¥209.41M ¥227.88M ¥266.18M ¥210.16M ¥117.46M ¥439.12M ¥385.95M ¥527.36M ¥958.37M ¥1.36B ¥1.57B ¥2.28B ¥2.59B ¥2.55B ¥2.77B ¥3.82B ¥3.43B ¥4.22B ¥1.27B ¥7.64B ¥0.00M
FCF Free Cash Flow
¥130.30M ¥164.81M ¥179.89M ¥143.31M ¥6.25M ¥297.47M ¥99.22M ¥-12.91M ¥491.54M ¥912.26M ¥1.28B ¥1.88B ¥1.48B ¥2.17B ¥2.25B ¥3.26B ¥2.88B ¥2.57B ¥-706.70M ¥5.50B ¥0.00M
FCFS Free Cash Flow Per Share
¥0.02 ¥0.03 ¥0.03 ¥0.02 ¥0.00 ¥0.05 ¥0.02 ¥-0.00 ¥0.08 ¥0.14 ¥0.20 ¥0.30 ¥0.23 ¥0.34 ¥0.35 ¥0.51 ¥0.45 ¥0.40 ¥-0.11 ¥0.97 ¥0.00